MAXIMUS INC
For the period ended Sep 30, 2024. Filed Nov 21, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Nov 21, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Liquidity and Capital Resources
Our primary sources of liquidity are cash on hand, cash from operations, and availability under our revolving credit facilities. As of September 30, 2024, we had $183.1 million in cash and cash equivalents. We believe that our current cash position, access to our revolvers, and cash flow generated from operations should be not only sufficient for our operating requirements but also to enable us to fund required long-term debt repayments, dividends, and any share purchases we might choose to make. We believe we have access to sufficient funds to manage through a potential shutdown of the U.S. federal government. See "Note 8. Debt and Derivatives" to the Consolidated Financial Statements for a more detailed discussion of our debt financing arrangements.
The below table summarizes our change in cash, cash equivalents, and restricted cash.
| Table MD&A 8: Net Change in Cash and Cash Equivalents and Restricted Cash | ||
|---|---|---|
| For the Year Ended September 30, | ||
| 2024 | 2023 | |
| (in thousands) | ||
| Cash flows: | ||
| Net cash provided by operating activities | $515,258 | $314,340 |
| Net cash used in investing activities | (129,104) | (80,963) |
| Net cash used in financing activities | (275,646) | (250,798) |
| Effect of foreign exchange rates on cash and cash equivalents and restricted cash | 3,164 | 2,717 |
| Net change in cash and cash equivalents and restricted cash | $113,672 | $(14,704) |
Net Cash Provided By Operating Activities
Net cash provided by operating activities increased by $200.9 million in fiscal year 2024 compared to fiscal year 2023. Almost all of this increase was a result of our increased profitability.
Our Days Sales Outstanding (DSO) has remained broadly consistent from September 30, 2022, when it was 62 days, through September 30, 2023 (60 days), and September 30, 2024 (61 days). Excluding the effect of our Receivables Purchase Agreement, our DSO would have been 65 days at both September 30, 2024 and 2023.
Net Cash Used In Investing Activities
We continue to make significant investments in our capital base, most notably in upgrading technology on our Federal MDE contracts; we anticipate this capital spend will decline in fiscal year 2025.
In addition, we invested $18 million in acquiring one of our established vendors.
During fiscal year 2024, we sold our businesses in Italy and Singapore, as well as our Canadian employment business. In fiscal year 2023, we sold a small commercial practice in the United Kingdom on payments terms which included installment payments.
Net Cash Used In Financing Activities
The principal drivers of financing cash flows are the Credit Agreement, our equity transactions, and restricted cash flows where we hold funds on behalf of customers or vendors.
During both fiscal years 2023 and 2022, we utilized our operating cash inflows to pay down debt and pay our dividends. In fiscal year 2024, we also used funds to purchase Maximus common stock.
Cash in Foreign Locations
We have no requirement to remit funds from our foreign locations to the United States. We will continue to explore opportunities to remit additional funds, taking into consideration the working capital requirements and relevant tax rules in each jurisdiction. When we are unable to remit funds back without incurring a penalty, we will consider these funds indefinitely reinvested until such time as these restrictions are changed. As a result, we do not record U.S. deferred income taxes on any funds held in foreign jurisdictions. We have not attempted to calculate our potential liability from any transfer of these funds, as any such transaction might include tax planning strategies that we have not fully explored. Accordingly, it is not possible to estimate the potential tax obligations if we were to remit all of our funds from foreign locations to the United States.
Free Cash Flow (Non-GAAP)
| Table MD&A 9: Free Cash Flow (Non-GAAP) | ||
|---|---|---|
| For the Year Ended September 30, | ||
| 2024 | 2023 | |
| (in thousands) | ||
| Net cash provided by operating activities | $515,258 | $314,340 |
| Purchases of property and equipment and capitalized software | (114,190) | (90,695) |
| Free cash flow (Non-GAAP) | $401,068 | $223,645 |
Material Cash Requirements from Contractual Obligations
Credit Facilities
Our principal debt agreement is with JPMorgan Chase Bank N.A. (the "Credit Agreement"). At September 30, 2024, we owed $1.15 billion under the Credit Agreement, with access to an additional $750.0 million through a revolving credit facility. Mandatory repayments are required under this agreement through May 2031, when the agreement ends, and must be renegotiated or the funds repaid.
We have included the following table showing our debt balances as of September 30, 2024, and their effective interest rates.
| Table MD&A 10: Debt Balances and Interest Rates as of September 30, 2024 | |||||
|---|---|---|---|---|---|
| September 30, 2024 | |||||
| Carrying value · Effective cash interest rate · Interest rate basis | |||||
| (dollars in thousands) | |||||
| Term Loan A - Hedged through May 2026 | $500,000 | 3.81% | Fixed rate of 2.31% plus margin. (1) | ||
| Term Loan A - Unhedged | 141,875 | 6.10% | Term SOFR reset monthly plus margin. (1) | ||
| Term Loan B - Hedged through September 2026 | 75,000 | 5.72% | Fixed rate of 3.72% plus margin. (1) | ||
| Term Loan B - Hedged through September 2025 | 75,000 | 6.09% | Fixed rate of 4.09% plus margin. (1) | ||
| Term Loan B - Unhedged | 348,750 | 6.60% | Term SOFR reset monthly plus margin. (1) | ||
| Debt held by international subsidiaries | 5,194 | 6.28% | Floating rate, reset quarterly. | ||
| Debt Principal | $1,145,819 | ||||
(1) Applicable margin ranges between 1% and 2%, based on our leverage ratio.
Our effective cash interest rate reflects the drivers of our cash interest payments as of September 30, 2024, which can change based upon the reset of the rates. Including the amortization of the upfront payments, our effective interest rate as of September 30, 2024 was 5.52%.
The Credit Agreement contains a number of covenants with which we are expected to comply. Failure to meet these requirements would result in a need to renegotiate the agreement or a requirement to repay our outstanding debt in full. There are two financial covenants, both defined in the Credit Agreement.
Our Consolidated Net Total Leverage Ratio means, for any twelve-month period, the ratio of our Funded Debt, offset by up to $150 million (which was $75 million under our previous agreement) of unrestricted cash (Consolidated Total Leverage), against our Consolidated EBITDA (as defined by the Credit Agreement). To comply with our Credit Agreement, this ratio cannot exceed 4.00:1.00 at the end of each quarter, with a step up to 4.50:1.00 under certain circumstances. This ratio also determines both our interest rate and the charge we pay on the unused component of our revolving credit facility, with the charge increasing as the leverage ratio increases.
Our Consolidated Net Interest Coverage Ratio means, for any twelve-month period, the ratio of our Consolidated EBITDA against our Consolidated Net Interest Expense as defined by the Credit Agreement. To comply with our Credit Agreement, this ratio cannot be less than 3.00:1.00 at the end of each quarter.
Consolidated EBITDA also drives certain permissions within the Credit Agreement, such as the level of investment we are entitled to make without seeking additional approval from our lenders.
Our Credit Agreement defines Consolidated EBITDA, as well as other components of the calculations above. The definition of Consolidated EBITDA requires us to include adjustments not typically included within EBITDA, including unusual, non-recurring expenses, certain non-cash adjustments, the pro forma effects of acquisitions and disposals, and estimated synergies from acquisitions. As a result, Consolidated EBITDA as defined by the Credit Agreement is calculated in a different manner from the Adjusted EBITDA we utilize to assess business performance and may not be comparable to EBITDA or related or similarly-titled measures presented by other companies.
We have summarized below the components of our two financial ratio calculations, including the components of Consolidated EBITDA as defined by the Credit Agreement, which are included within our financial statements. At September 30, 2024, we were in compliance with all applicable covenants of our Credit Agreement. We do not believe that these covenants represent a significant restriction in our ability to operate our business or to pay our dividends.
| Table MD&A 11: Reconciliation of Net Income to Consolidated EBITDA as defined by our Credit Agreement | ||
|---|---|---|
| For the Year Ended September 30, | ||
| 2024 | 2023 | |
| (in thousands) | ||
| Net income | $306,914 | $161,792 |
| Adjustments: | ||
| Interest expense | 82,440 | 84,138 |
| Other expense, net | (450) | 363 |
| Provision for income taxes | 99,595 | 48,501 |
| Amortization of intangibles | 91,570 | 94,591 |
| Stock compensation expense | 35,349 | 29,522 |
| Acquisition-related expenses | 3,218 | 575 |
| Loss on sale of businesses | 1,018 | 883 |
| Depreciation and amortization of property, equipment, and capitalized software | 33,957 | 54,725 |
| Pro forma and other adjustments permitted by our Credit Agreement | 72,172 | 69,892 |
| Consolidated EBITDA (as defined by our Credit Agreement) | $725,783 | $544,982 |
| Table MD&A 12: Consolidated Net Total Leverage Ratio | ||
|---|---|---|
| For the Year Ended September 30, | ||
| 2024 | 2023 | |
| (in thousands, except ratio data) | ||
| Funded Debt (as defined by our Credit Agreement) | $1,145,819 | $1,257,529 |
| Cash and cash equivalents up to $150 million | 150,000 | 65,405 |
| Consolidated Net Total Leverage (as defined by our Credit Agreement) | $995,819 | $1,192,124 |
| Consolidated Net Total Leverage Ratio (as defined by our Credit Agreement) | 1.37 | 2.19 |
| Table MD&A 13: Consolidated Net Interest Coverage Ratio | ||
|---|---|---|
| For the Year Ended September 30, | ||
| 2024 | 2023 | |
| (in thousands, except ratio data) | ||
| Consolidated EBITDA (as defined by our Credit Agreement) | $725,783 | $544,982 |
| Interest expense | 82,440 | 84,138 |
| Components of other income/expense, net allowed in ratio calculation | 2,533 | 2,684 |
| Consolidated Net Interest Expense (as defined by our Credit Agreement) | $84,973 | $86,822 |
| Consolidated Net Interest Coverage Ratio (as defined by our Credit Agreement) | 8.54 | 6.28 |
Leases
As of September 30, 2024, we reported current and long-term operating lease liabilities of $47.7 million and $97.2 million, respectively. These balances represent our contractual obligation to make future payments on our leases, discounted to reflect our cost of borrowing. The majority of these leases are for real estate. In the event that we vacate a location, we may be obligated to continue making lease payments. Where possible, we mitigate this risk by including clauses allowing for the termination of lease agreements if the contract the location covers is terminated by our customer. See "Note 10. Leases" to the Consolidated Financial Statements for information regarding our leases, including obligations by fiscal year.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.